CELLCOM ISRAEL (Israel) Today

CELLCOM ISRAEL is trading at 1032.00 as of the 26th of September 2021, a 0.58 percent increase since the beginning of the trading day. The stock's open price was 1026.0. Equity ratings for CELLCOM ISRAEL LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of July 2021 and ending today, the 26th of September 2021. Click here to learn more.
Valuation Profit Patterns
Check how we calculate scores

CELLCOM ISRAEL Stock Profile

Cellcom Israel Ltd. provides cellular communications services in Israel. Cellcom Israel Ltd. was incorporated in 1994 and is headquartered in Netanya, Israel. CELLCOM ISRAEL is traded on Tel Aviv Stock Exchange in Israel. more on CELLCOM ISRAEL
CELLCOM ISRAEL LTD is not yet fully synchronised with the market data
CELLCOM ISRAEL LTD generates negative expected return over the last 90 days
CELLCOM ISRAEL LTD has high historical volatility and very poor performance
The company reported the revenue of 3.96 B. Net Loss for the year was (88 M) with profit before overhead, payroll, taxes, and interest of 876 M.
About 44.0% of the company shares are held by company insiders
Legal NameCELLCOM ISRAEL LTD
Chief Executive OfficerAvi Gabbay  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of CELLCOM ISRAEL's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
CELLCOM ISRAEL LTD (CEL) is traded on Tel Aviv Stock Exchange in Israel and employs 2,954 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.68 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CELLCOM ISRAEL's market, we take the total number of its shares issued and multiply it by CELLCOM ISRAEL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. CELLCOM ISRAEL LTD operates under Communication Services sector and is part of Telecom Services industry. The entity has 162.78 M outstanding shares. CELLCOM ISRAEL LTD has accumulated about 987 M in cash with 1000 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.34.
Check CELLCOM ISRAEL Probability Of Bankruptcy

CELLCOM Stock Price Odds Analysis

What are CELLCOM ISRAEL's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of CELLCOM ISRAEL jumping above the current price in 90 days from now is roughly 97.0%. The CELLCOM ISRAEL LTD probability density function shows the probability of CELLCOM ISRAEL stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon CELLCOM ISRAEL has a beta of 0.4025 suggesting as returns on the market go up, CELLCOM ISRAEL average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding CELLCOM ISRAEL LTD will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. CELLCOM ISRAEL LTD is significantly underperforming DOW.
 Odds Down 1032.0HorizonTargetOdds Up 1032.0 
2.98%90 days
 1,032 
97.00%
Based on a normal probability distribution, the odds of CELLCOM ISRAEL to move above the current price in 90 days from now is roughly 97.0 (This CELLCOM ISRAEL LTD probability density function shows the probability of CELLCOM Stock to fall within a particular range of prices over 90 days) .

CELLCOM ISRAEL Historical Income Statement

CELLCOM ISRAEL LTD Income Statement is one of the three primary financial statements used for reporting CELLCOM's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of CELLCOM ISRAEL LTD revenue and expense. CELLCOM ISRAEL Income Statement primarily focuses on the company's revenues and expenses during a particular period.
CELLCOM ISRAEL Direct Expenses is projected to decrease significantly based on the last few years of reporting. The past year's Direct Expenses was at 2.8 Billion. The current year Revenues is expected to grow to about 4.7 B, whereas Net Income is forecasted to decline to (174.5 M). View More Fundamentals

CELLCOM Stock Against Markets

Picking the right benchmark for CELLCOM ISRAEL stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in CELLCOM ISRAEL stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for CELLCOM ISRAEL is critical whether you are bullish or bearish towards CELLCOM ISRAEL LTD at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CELLCOM ISRAEL stock to make a market-neutral strategy. Peer analysis of CELLCOM ISRAEL could also be used in its relative valuation, which is a method of valuing CELLCOM ISRAEL by comparing valuation metrics with similar companies.

CELLCOM ISRAEL Corporate Directors

CELLCOM ISRAEL corporate directors refer to members of a CELLCOM ISRAEL board of directors. The board of directors generally takes responsibility for the CELLCOM ISRAEL's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of CELLCOM ISRAEL's board members must vote for the resolution. The CELLCOM ISRAEL board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Shlomo Waxe - Independent DirectorProfile
Saul Lapidus - DirectorProfile
Ronit Baytel - Independent/External DirectorProfile
Shmuel Hauzer - DirectorProfile
Continue to Trending Equities. Note that the CELLCOM ISRAEL LTD information on this page should be used as a complementary analysis to other CELLCOM ISRAEL's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Tools for CELLCOM Stock

When running CELLCOM ISRAEL LTD price analysis, check to measure CELLCOM ISRAEL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CELLCOM ISRAEL is operating at the current time. Most of CELLCOM ISRAEL's value examination focuses on studying past and present price action to predict the probability of CELLCOM ISRAEL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CELLCOM ISRAEL's price. Additionally, you may evaluate how the addition of CELLCOM ISRAEL to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go